Guangrong Zheng - Concepedia

Author

Guangrong Zheng

Also Known As

G. ZHENG, G. Zheng, G.S. Zheng, Guang-rong Zheng, Guangrong Zheng, GuoChuang Zheng, Guoyi Zheng, Zheng, Guangrong, Zheng,Guangrong

234

Publications

5.8K

Citations

H-Index

104

Concepts

All Affiliations

University of Florida University of Kentucky University of Arkansas for Medical Sciences The University of Texas Health Science Center at San Antonio Florida College

About

Guangrong Zheng is an author at University of Florida specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	37	2K
2	Natural Sciences	10	10	499
3	Social Sciences	9	9	156
4	Engineering	6	6	150
5	Health Sciences	5	5	113

Guangrong Zheng

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity Sajid Khan, Xuan Zhang, Dongwen Lv, Nature Medicine OncologyMedicinePotent Antitumor ActivityImmune Checkpoint InhibitorAnti-cancer Agent	2019	608
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy Pataje G.S. Prasanna, Deborah E. Citrin, Jeffrey Hildesheim, JNCI Journal of the National Cancer Institute Anti-agingAgingPathologyBiogerontologyCancer Biology	2021	313
Web 3DNA--a web server for the analysis, reconstruction, and visualization of three-dimensional nucleic-acid structures Guangrong Zheng, Xiang‐Jun Lu, Wilma K. Olson Nucleic Acids Research	2009	312
Discovery of piperlongumine as a potential novel lead for the development of senolytic agents Yingying Wang, Jianhui Chang, Xingui Liu, Aging	2016	262
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity Yonghan He, Xuan Zhang, Jianhui Chang, Nature Communications	2020	246
The curcumin analog EF24 is a novel senolytic agent Wen Li, Yonghan He, Rongping Zhang, Aging Curcumin Analog Ef24ApoptosisImmunologyCell DeathChemical Biology	2019	154
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity, Dongwen Lv, Pratik Pal, Xingui Liu, Nature Communications	2021	140
Oxidation resistance 1 is a novel senolytic target Xin Zhang, Suping Zhang, Xingui Liu, Aging Cell	2018	122
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas Yonghan He, Raphael Koch, Vivekananda Budamagunta, Journal of Hematology & Oncology	2020	118
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs Yufeng Xiao, Jia Wang, Lisa Zhao, Chemical Communications	2020	110

Page 1